A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off‐therapy relapse: An observational study-Reference-Cited by-同舟云学术

A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off‐therapy relapse: An observational study

Published:2022-08-08 Issue:11 Volume:37 Page:2164-2172
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J of Gastro and Hepatol

Author:

Peng Chien‐Wei¹²^ORCID,Jeng Wen‐Juei¹²^ORCID,Yang Hwai‐I³,Liu Yen‐Chun¹²^ORCID,Chien Rong‐Nan¹²⁴,Liaw Yun‐Fan²⁴

Affiliation:

1. Department of Gastroenterology and Hepatology Chang Gung Memorial Hospital, Linkou branch Taoyuan Taiwan

2. College of Medicine Chang Gung University Taoyuan Taiwan

3. Genomic Research Center Academia Sinica Taipei Taiwan

4. Liver Research Unit Chang Gung Memorial Hospital, Linkou branch Taoyuan Taiwan

Funder

National Science Council

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15966

Reference30 articles.

1. Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. The times they are a-changing – A refined proposal for finite HBV nucleos(t)ide analogue therapy

5. Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study);Journal of Hepatology;2024-08

2. When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?;Current Hepatology Reports;2024-02-23

3. Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals;Alimentary Pharmacology & Therapeutics;2024-01-18

4. Serious adverse events after cessation of nucleos(t)ide analogues in individuals with chronic hepatitis B: A systematic review and meta-analysis;JHEP Reports;2023-01